Lycia Therapeutics, Inc. (LYCA) SEC filings
LYCANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$31.35+0.43 (+1.39%)
Close on Nov 18, 2026Market cap –P/E –Yield –
SEC filings
1 of Lycia Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 26, 2026 | Oct 26, 2026 | SEC EDGAR |
See a number that looks wrong?